Status:
COMPLETED
Chronic Presence of Epstein Barr Virus in Epithelial Cells From Gingiva is Associated With Periodontitis
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Chronic Periodontitis
Aggressive Periodontitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The etiopathogenesis of periodontal disease results from complex interaction between infectious agents, mainly including bacteria, and host cellular and humoral immune responses. However it is thought...
Eligibility Criteria
Inclusion
- 10 patients affected by chronic periodontitis
- 10 patients affected by aggressive periodontitis
- 10 healthy patients (orthodontics extraction)
- Subject who have read and understood the information note relative under investigation and who have signed the informed consent
- major patient
Exclusion
- Patient with no contre-indication to periodontal treatment
- Patient with serious blood disease
- Patient who exhibits systemic condition incompatible with realization of the study
- Patient treated with oral retinoids, bisphosphonates, oral anticoagulants and anticonvulsivants
- Patient who presents a buccal carcinoma treated with radiotherapy
- Patient who have received during the past 6 months: anti-inflammatory drugs, anti-cancerous or immunosuppressive chemiotherapy
- Patient who presents a linguistic or psychic incapacity to understand information
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2014
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01246596
Start Date
January 1 2011
End Date
May 5 2014
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Severine VINCENT
Nice, France, 0600